diacetyldichlorofluorescein has been researched along with adenosine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanno, M; Mori, S; Ohkohchi, N; Orii, T; Satomi, S; Taguchi, Y; Terashima, T | 1 |
Lasley, RD; Mentzer, RM; Narayan, P | 1 |
Lu, Y; Marucha, PT; Sroussi, HY; Villines, D; Zhang, QL | 1 |
3 other study(ies) available for diacetyldichlorofluorescein and adenosine
Article | Year |
---|---|
Lipid peroxidation of parenchymal and nonparenchymal hepatocytes during cold preservation and after reoxygenation in rats.
Topics: Adenosine; Allopurinol; Animals; Fluoresceins; Fluorescent Dyes; Glutathione; Hypertonic Solutions; Insulin; Kinetics; Lipid Peroxidation; Lipid Peroxides; Liver; Luminescent Measurements; Male; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Solutions; Time Factors; Tissue Preservation | 1993 |
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
Topics: Adenosine; Aniline Compounds; Animals; Calcium; Decanoic Acids; Drug Synergism; Fluoresceins; Fluorescent Dyes; Glyburide; Heart Ventricles; Hydroxy Acids; Ion Transport; Male; Microscopy, Fluorescence; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidation-Reduction; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Purinergic P1; Xanthenes; Xanthines | 2001 |
S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: involvement of adenosine metabolites.
Topics: Adenosine; Adenosine Deaminase; Calgranulin A; Calgranulin B; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Neutrophil Activation; Neutrophils; Oxidation-Reduction; Protein Kinase C; Purinergic P1 Receptor Antagonists; Reactive Oxygen Species; Receptors, Purinergic P1; Recombinant Proteins; Time Factors | 2010 |